Home > Healthcare > Medical Devices > Diagnostic Devices > Ovulation Testing Kits Market

Ovulation Testing Kits Market Size

  • Report ID: GMI7248
  • Published Date: Nov 2023
  • Report Format: PDF

Ovulation Testing Kits Market Size

Ovulation Testing Kits Market size was valued at USD 1.8 billion in 2022 and is estimated to reach USD 4.2 billion by 2032. Ovulation testing kits are diagnostic tools that help women, determine the most fertile days of their menstrual cycle by detecting the surge in hormones, which precedes ovulation.


Ovulation Testing Kits Market

To understand key trends  
Download Free Sample

The WHO estimates that polycystic ovary syndrome (PCOS) affects an estimated 8-13% of reproductive-aged women, and up to 70% of affected women remain undiagnosed. Therefore, the increasing prevalence of PCOS and hormonal disorders underscores the growing demand for accurate ovulation testing kits, enabling affected women to track their cycles and enhance their conception prospects.


Furthermore, with the burgeoning awareness surrounding in-vitro fertilization (IVF) services, an increasing number of couples are actively pursuing avenues to enhance their fertility. Thus, ovulation testing kits play a pivotal role in this journey, empowering individuals to meticulously time their fertility treatments and, in turn, heighten their prospects of achieving successful IVF.


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global ovulation testing kits indystry was valued at USD 1.8 billion in 2022 and is estimated to reach USD 4.2 billion by 2032.

The pharmacies and drugstores segment accounted for over 41% market share in 2022 and will grow through 2032 as these stores offer easy accessibility, provide professional guidance, and a variety of product options.

U.S. ovulation testing kits market accounted for USD 672 million in 2022 and is predicted to witness substantial growth through 2032 primarily due to the region’s high fertility awareness, robust healthcare infrastructure, consumer affluence, and effective marketing efforts.

Swiss Precision Diagnostics GmbH (Clearblue), ClinicalGuard, Wondfo, AccuMed, PREGMATE, iProven, and Wellify (Piramal group), Femometer, Proov, Easy@Home Fertility, Ro, Fairhaven Health, and Prega News (Mankind pharma).

Ovulation Testing Kits Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 340
  • Countries covered: 22
  • Pages: 325
 Download Free Sample